Peshori, Kavita R., William F. Collins III, and Lorne M. Menlow input resistance, high rheobase and short-duration AHP dell. EPSP amplitude modulation at the rat Ia-alpha motoneuron increase in amplitude during high-frequency stimulation synapse: effects of GABA B receptor agonists and antagonists. J. (positive modulation). Positive correlations have also been Neurophysiol. 79: 181-189, 1998. The object of this study was to observed between posttetanic potentiation and EPSP ampliexamine the relationship between excitatory postsynaptic potential tude after high-frequency stimulation (Davis et al. 1985, (EPSP) amplitude, posttetanic potentiation, and EPSP amplitude 1987). These observations suggest that the processes that modulation at synapses made by group Ia afferents on motoneurons underlie EPSP amplitude modulation and potentiation conin the rat. These relationships were evaluated in cells in untreated tribute to the distribution of Ia EPSP amplitudes across motorats and in cells in rats treated with the g-aminobutyric acid-B neurons ).
By analogy with peripheral systems (Del Castillo and nals and consequently probability of transmitter release from them. Katz 1954; Frank 1973; Gertler and Robbins 1978; Kuno There was no evidence for postsynaptic action of these drugs from 1964), it was hypothesized that the differences in frequencymeasurement of their effects on motoneuron properties. During dependent behavior at these synapses resulted from differhigh-frequency stimulation (32 shock bursts at 167 Hz), EPSP ences in presynaptic properties, specifically in probability of amplitude either decreased (negative modulation) or increased transmitter release (Collins et al. 1984) . A buildup of Ca 2/ (positive modulation) in response to successive stimuli at different in the presynaptic terminals from repetitive stimulation (reconnections. In untreated rats this frequency-dependent amplitude sidual Ca 2/ ) is considered to lead to an increase in the modulation behavior was inversely but weakly correlated with probability of transmitter release resulting in facilitation of EPSP amplitude measured at low frequency. Intravenous (iv) adthe postsynaptic response during a high-frequency burst ministration of the GABA B agonist, baclofen, produced a marked and progressive decrease in EPSP amplitude measured at low fre- (Katz and Miledi 1968; Martin 1967, 1968) . quency coincident with a change in frequency-dependent EPSP At connections with high initial probability of transmitter amplitude modulation toward more positive values (synaptic facilirelease (large initial values of P) and consequently large tation). In contrast, an increase in EPSP amplitude occurred after EPSP amplitudes, depression is seen during high-frequency iv administration of the GABA B antagonist CGP-35348 that was stimulation, despite the residual Ca 2/ buildup, possibly beaccompanied by a negative shift in EPSP amplitude modulation cause of the unavailability or depletion of adequate releasduring high-frequency stimulation. The negative shift in EPSP amable transmitter (Betz 1970) or inability to release available plitude modulation (synaptic depression) after CGP-35348 applitransmitter on subsequent stimuli (Korn et al. 1981) . At cation was much smaller than the positive shift induced by baclofen connections with low initial probability of release, EPSP when normalized to the change in EPSP amplitude. Posttetanic amplitude increases during high-frequency stimulation. Thus potentiation decreased after baclofen but did not increase after CGP-35348. The relationship between modulation and EPSP am-in this work we have assumed that the behavior of EPSP plitude was much steeper after GABA B receptor manipulation in amplitude during high-frequency stimulation is an index of either direction than that observed in the population of motoneuthe average probability of release at that connection. rons in untreated preparations. This suggests that in the rat differ-
The focus of the present study was to investigate the deences in probability of release play at most a small role in determinpendence of EPSP amplitude during high-frequency stimulaing EPSP amplitude across the motoneuron pool. tion on probability of transmitter release more explicitly. The approach was to manipulate probability of release pharmacologically by using agonists and antagonists of the g-I N T R O D U C T I O N aminobutyric acid (GABA B ) receptor. This receptor, which A series of studies in the cat has illustrated that the succesis known to be present on terminals of Ia fibers (Bowery et sive excitatory postsynaptic potential (EPSPs) generated in al. 1987; Price et al. 1984) , acts to control entry of Ca 2/ motoneurons of different types during high-frequency stimuinto sensory neurons (Deisz and Lux 1985;  Dolphin and lation of Ia afferent fibers differ in their amplitude modula-Scott 1987; Dunlap and Fischbach 1981) . Previous studies tion (Collins et al. 1984; Honig et al. 1983; suggested that the GABA B agonist baclofen reduces mono-1995). Large-amplitude EPSPs generated in motoneurons synaptic EPSP amplitude (Edwards et al. 1989 ; Lev Tov et with a small value of rheobase, large input resistance, Peng and Frank 1989) by decreasing probability afterhyperpolarization (AHP) of long duration tend to unof transmitter release (Edwards et al. 1989 ; Peng and Frank dergo a progressive decrease in amplitude during high-fre-1989) because of reduction in Ca 2/ entry into the presynapquency stimulation (negative modulation, see METHODS ). tic terminals (Curtis et al. 1997) . The GABA B antagonist CGP-35348 is also known to reduce the level of presynaptic Conversely, small-amplitude EPSPs in motoneurons with a of the voltage decay of the last (32nd) EPSP in the burst between inhibition in the spinal cord (Curtis 1998; Curtis and Lacey times representing where the onset and peak of an imaginary 33rd 1994). By using these agents, the aim in the present experi-EPSP would have occurred. ments was to examine in detail the relationship between These two stimulus paradigms have been used in previous stud-EPSP amplitude, EPSP amplitude modulation, and postteies in cats (Collins et al. 1984 (Collins et al. , 1988 Davis et al. 1985 Davis et al. , 1987  tanic potentiation in individual cells. One question was Koerber and Mendell 1991; Mendell et al. 1995) for several reawhether activation and blockade of the GABA B receptor sons. First, both frequencies are within the normal physiological yields the same functional relationship between EPSP amplirange for Ia afferents (Prochazka et al. 1977 ; Loeb and Duysens tude modulation and amplitude. A second question was 1979). Second, no systematic variability is observed in the ampliwhether or not this relationship is similar to that observed tude of Ia-motoneuron EPSPs during 18 Hz stimulation (Collins et al. 1984) . Thus EPSP 18 Hz is considered to be the control EPSP across the population of connections. This would speak to for comparison with EPSPs generated at higher frequencies of the question of whether or not differences in EPSP amplitude stimulation. Third, 32 shock bursts at 167 Hz is an optimal parain different motoneurons can be attributed to differences in digm for revealing the heterogeneity in the response of Ia-motoneuprobability of transmitter release. Preliminary results from ron connections to repetitive stimulation. At frequencies ú167 these studies have been published in abstract form (Mendell Hz, most Ia-motoneuron synapses tend to exhibit depression and et al. 1991; Peshori et al. 1991 Peshori et al. , 1993 . conduction failure in afferent terminal branches can occur (Collins et al. 1984) . In preliminary studies we found these criteria to be valid for the rat as well, and for the sake of consistency and easier M E T H O D S comparison between species, we chose the same stimulus paradigms as those used in the cat. Adult, male Sprague-Dawley rats (300-500 g) were anesthe-To assess the change in EPSP amplitude during high-frequency tized with a mixture of ketamine and xylazine (90 and 10 mg/kg, stimulation, EPSP amplitude modulation, potentiation and facilitaim, respectively) and anesthesia was maintained by a continuous tion/depression (F-D) were calculated by using the following forinfusion (0.4-1.6 ml/hr) of this mixture diluted in 10% dextrose mulae: saline. The rats were mechanically ventilated and heart rate, ECG, blood pressure, expired CO 2 , and rectal temperature were moni- expose segments T 12 -S 2 of the spinal cord. The left medial gastrocnemius (MG) and lateral gastrocnemius-soleus (LGS) nerves were Modulation is defined as the change in EPSP amplitude during a exposed and cut. The proximal cut ends were placed on bipolar high-frequency, 32 shock burst and was calculated as the ratio of platinum stimulating hook electrodes and covered with warm minthe amplitude of the EPSPs at the end of the burst (average of eral oil. The dura overlying the spinal cord was removed and the 30th and 31st EPSPs) to the amplitude of the first EPSP within cord was covered with mineral oil. A platinum ball electrode was the burst (Eq. 1). A modulation value õ1 represents a decrease placed on the dorsal columns and the stimulus intensities for the in EPSP amplitude during the burst and is termed negative modula-MG and LGS nerves were set at 2 times threshold for the dorsal tion. A modulation value ú1 signifies positive modulation, i.e., an column response to ensure maximal activation of group Ia afferent increase in EPSP amplitude during the burst. Because the interburst fibers. Incoming afferent volleys were monitored in this manner interval used in averaging bursts was 2 s, the initial EPSP in each to ensure faithful conduction of afferent volleys during high-freburst (except the first burst) was often potentiated in amplitude quency stimulation. because of the influence of the previous burst (Collins et al. 1984 ; Intracellular recordings were made by using glass microelec- Davis et al. 1985) . This potentiation was quantified by calculating trodes filled with 3 M potassium acetate with tip resistance between the ratio of the amplitude of the first averaged EPSP in a high-4 and 16 MV. Impaled motoneurons were identified as MG or LGS frequency burst to the amplitude of the averaged control EPSP 18 Hz by their response to antidromic stimulation of the MG or LGS (Eq. 2). The F-D ratio represents the amplitude of the EPSP at muscle nerve and the latency was used to calculate axonal conducthe end of the burst referred to the value measured at low-frequency tion velocity. The analysis was restricted to motoneurons with stimulation (EPSP 18 Hz ). Because the first EPSP in the burst antidromic action potential amplitudes ú75 mV. Motoneuron rheo-(EPSP 1 ) was generally potentiated, EPSP 1 ú EPSP 18 Hz [potentiabase was measured as the minimum intracellular depolarizing curtion (Eq. 2) ú 0] and so F-D was generally more positive than rent (50 ms duration) required to generate an action potential. modulation (see Fig. 3 ). Input resistance (R n ) was measured as the averaged (n Å 64) amplitude of the voltage change in response to 1 nA of hyperpolar-Pharmacological studies izing current (50-ms duration) injected intracellularly. Before measuring R n , the averaged record was corrected for membrane poten-After obtaining measurements of electrical and synaptic properties at a given Ia-motoneuron connection, either l-(0) baclofen tial Sag by using a procedure similar to that used by Zengel et al. (1985) .
(10 mg/kg in saline, Ciba-Geigy, Suffern, NY), ({) baclofen (10 mg/kg in phosphate buffered saline, Sigma Chemical, St. Louis, Composite Ia-EPSPs were elicited by stimulation of the heteronymous muscle nerve. Two stimulus paradigms were employed; MO or Research Biochemicals International, Natick, MA), CGP-35348 (30-400 mg/kg in saline, Ciba-Geigy, Basel), or saline first, low-frequency (18 Hz) trains and second, 32 shock bursts at high-frequency (167 Hz) delivered every 2 s. Successive triggered was injected intravenously while the intracellular penetration was maintained. A single injection was usually sufficient for baclofen events were averaged in register (n Å 256 for 18 Hz trains, n Å 64 for 167-Hz bursts) and the amplitudes of the averaged EPSPs effects which were not reversible over the intervals studied here (up to 4 h). In the case of CGP-35348 the initial small dose were measured (EPSP 18 Hz ; and for the burst, EPSP 1 , EPSP 2 , . . . , EPSP 32 ). A correction factor was added to the measurements of often did not have any effect or it wore off very quickly and supplementary injections were given. This accounts for the wide all but the first EPSP within a burst to compensate for the summation of each EPSP with the falling phase of the previous EPSP. range of dosages for CGP-35348. The measurements were repeated immediately after drug administration and periodically throughout The value of this correction factor was calculated as the magnitude 1985). In contrast, a significant negative correlation was detected between F-D and EPSP amplitude (r Å 00.25; R E S U L T S P õ 0.01; Fig. 3C ), which was nearly identical to that observed for modulation. Thus the dependence of modulation Composite Ia-motoneuron EPSP amplitude on EPSP amplitude at rat Ia-motoneuron synapses results from changes occurring during bursts of high-frequency The amplitudes of composite EPSPs were measured in a total of 103 motoneurons in response to 18 Hz stimulation stimulation (i.e., facilitation and depression), rather than changes between bursts (i.e., potentiation). ( Fig. 1A) and varied from 0.15 mV to 3.35 mV with a mean of 1.15 { 0.68 (SD) mV. Motoneuron rheobase varied from 0.8 to 19.5 nA (mean Å 8.1 { 3.9 nA; n Å 100) and Manipulation of EPSP amplitude with baclofen and motoneuron input resistance varied from 1.2 to 4.1 MV CGP-35348 (mean Å 2.2 { 0.6 MV; n Å 38). EPSP amplitude at 18
A major aim of these experiments was to determine ex-Hz was weakly but significantly correlated with both motoplicitly the effects of manipulating the probability of transneuron rheobase (linear regression, r Å 00.23, P õ 0.02; Fig. 2A ) and motoneuron input resistance (r Å 0.43, P õ 0.01; Fig. 2B ).
Frequency dependence of EPSP amplitude
EPSP amplitude modulation during 32 shock bursts ( Fig.  1B) was calculated using Eq. 1 and varied from 0.46 (negative modulation) to 1.56 (positive modulation) with a mean of 1.25 { 0.2 (n Å 103). As in the cat, large EPSPs tended to exhibit more negative modulation than small EPSPs. Plotting modulation against EPSP amplitude (Fig. 3A ) revealed a significant negative correlation, but with a relatively small correlation coefficient (r Å 00.25, P õ 0.01). The slope of the linear regression is 00.08, suggesting a small dependence of amplitude modulation on EPSP amplitude. No correlation was detected between amplitude modulation and either motoneuron rheobase or motoneuron input resistance.
One of the complications in evaluating differences in amplitude modulation (Eq. 1) across the motoneuron pool is that the first EPSP in the burst is often potentiated with respect to the low frequency (18 Hz) EPSP amplitude (Davis et al. 1985 (Davis et al. , 1987 . This is evident in the averaged records of the present study ( Fig. 1 ) and occurs as a consequence of the high-frequency activity of the preceding burst (2-s interburst interval). Thus differences in EPSP amplitude modulation across the population of motoneurons could result from systematic differences either in potentiation of the first EPSP in the burst or in faciliation-depression (F-D) behavior during the burst, or both. The contribution of these factors to the dependence of amplitude modulation on EPSP amplitude was examined in more detail by evaluating the changes in EPSP amplitude, modulation, and potentiation of 070 { 14%, 67 { 46%, and 023 { 14%, respectively, although these are approximate values because they were obtained over different treatment intervals (i.e., until the motoneuron penetration was lost). The decreases in EPSP amplitude and potentiation and the positive shift in modulation could be detected within 2 min after application of baclofen ( Fig. 6A ) and persisted for as long as the motoneuron penetration was maintained (up to 2.8 h). These effects did not wear off over the several hours that the intracellular penetration was maintained. Administration of the GABA B antagonist CGP-35348 permitted evaluation of these same relationships when probability of release was increased (Fig. 4, C and D) . Intravenous administration of CGP-35348 produced a rapid and marked increase in EPSP amplitude (50 { 18%, n Å 8). However only a small change in amplitude modulation was observed (013 { 9%, n Å 8; Figs. 4-6), even after repeated doses (see METHODS ) unlike the finding after baclofen administration where modulation underwent substantial changes in conjunction with those in EPSP amplitude . Thus in the example of Fig. 4 (C and D) , EPSP amplitude increased from 1.90 mV to a maximum of 2.95 mV but modulation decreased only slightly (from 1.02 to 0.83). Unexpectedly, a small but significant decrease (011 { 6%, n Å 8) in potentiation of the initial EPSP (i.e., potentiation at 2 s) was observed after CPG-35348 administration (see DISCUSSION ).
To better quantify the relationship between amplitude and modulation, we plotted the change in amplitude modulation as a function of the change in EPSP amplitude for individual motoneurons in baclofen-and CPG-35348-treated rats (Fig.  7) . Each straight line represents the least squares fit of the points in an individual experiment obtained after the drug was administered (as shown in Fig. 6, as mitter release pharmacologically on EPSP amplitude and EPSP amplitude modulation. In 12 motoneurons, baclofen was administered iv while the motoneuron penetration was maintained and EPSP amplitude, amplitude modulation, and potentiation were measured during the period of EPSP amplitude decline. An example of this is shown in Fig. 4, A increased concomitantly from 0.86 to 1.77. In addition, the after (D) CGP-35348 administration. Note that baclofen administration potentiation ratio decreased from 1.4 to 1.18 (016%). Simiproduces a decrease in EPSP 18 Hz amplitude and a positive shift in amplitude lar data were obtained at all connections studied in this way modulation during high-frequency stimulation, whereas the opposite occurs after CGP-35348. (Fig. 5 the population of medial gastrocnemius motoneurons was markedly different (00.08, n Å 103). The shape of the EPSP was examined before and after administration of baclofen (n Å 8) and CGP-35348 (n Å 7). After baclofen administration, no change was observed in the shape of the EPSP in a majority of the cells (5/8). However, faster decay of the EPSP was detected in one cell and, at two others, the rise time of the EPSPs appeared to be faster. After CGP-35348 administration, there was no change in the time course or shape of the EPSPs in five of the seven cells examined. One of the remaining cells exhibited a faster EPSP decay whereas the other one exhibited a slower EPSP decay.
Peak potentiation
As pointed out above, application of baclofen or CGP-35348 generally reduced potentiation of the first EPSP in FIG . 5. Histograms of EPSP 18 Hz amplitude (A), modulation (B), and the burst evoked 2 s after the preceding burst. In previous potentiation (C) in untreated rats (top) and after baclofen (middle) or work in the cat, we demonstrated that peak potentiation after administration. Control group (n Å 103) was either untreated rats or ones that had been injected with saline. Values after the burst is reached 50-100 ms after the burst and it then baclofen (n Å 32) were steady-state values from cells ( n Å 12) followed undergoes a decrease (Davis et al. 1985 (Davis et al. , 1987 . In a small for several hours immediately after baclofen was administered and values subset of cells studied here, we examined potentiation 50obtained from other cells (n Å 20) impaled up to 3.3 h after baclofen had 100 ms after the burst and found that it was generally greater been given. In case of CGP-35348 only 8 cells studied over course of administration of this drug are shown because unlike effects of baclofen, than that seen 2 s after the burst. During baclofen administraeffects of CGP-35348 appeared to be short-lived. Histograms document tion, peak potentiation declined, whereas after CGP-35348 smaller values of EPSP amplitude and potentiation and more positive values it was unaffected. of modulation after baclofen and larger values of EPSP amplitude, slightly more negative (less positive) values of modulation and identical values of potentiation after ments were made at individual connections after administration of baclofen. Because of the small number of measurements in some cases or because the rapid decrease in amplitude and increase in amplitude modulation caused many of the points to be clustered, the data at only six connections exhibited a significant correlation. However, all 12 are shown to demonstrate the similarity in the results. For CGP-35348 experiments, 5-23 measurements were made per cell and the plots revealed qualitatively similar results although the slope was substantially smaller than in the case of baclofen. Five of the eight experiments yielded a significant correlation. It should be noted that the EPSP amplitude before drug treatments was similar in all these experiments and became smaller after baclofen and larger after CGP-35348 with corresponding changes in the modulation values.
We have previously demonstrated a semilogarithmic relationship between modulation and EPSP amplitude for Ia EPSPs in cat medial gastrocnemius motoneurons (Collins et al. 1988 ). We replotted the data for the subset of experiments with significant correlations displayed in Fig. 7 , using ''ln amplitude'' as abcissa (i.e., semilog plot; Fig. 8 ). Although the effect of CGP-35348 on modulation is much smaller than that seen with baclofen ( Fig. 7) , the slopes of the semilogarithmic regression lines were similar. In the case of baclofen-treated motoneurons, the slopes of the regression lines between modulation and ln EPSP amplitude ranged from 00.29 to 00.63 (mean 00.55 { 0.14, n Å 6). The studied with CGP-35348 ranged from 00.22 to 00.42 (mean in two different motoneurons in different preparations. Note opposite effects 00.36 { 0.08, n Å 5). However, the slope of the regression of these agents on EPSP amplitude and modulation and nonreciprocal ef- 
Effects of baclofen and CGP-35348 on motoneuron properties
To assess the possibility that baclofen or CGP-35348 may influence EPSP amplitude via a postsynaptic action, motoneuron input resistance and rheobase were measured before and after drug administration. In addition, repeated measurements were obtained from motoneurons in the absence of drug administration. In no case was a significant change (paired sample t-test) in motoneuron input resistance or rheobase detected after drug administration or with repeated measurements. Before and after baclofen treatment, mean motoneuron input resistances were 1.53 and 1.67 MV, respectively (9.8%, P ú 0.1, n Å 10), and mean rheobase values were 8.66 and 8.63 nA, respectively (00.5%, P ú 0.9, n Å 8). After CGP-35348 treatment, an increase in mean input resistance from 1.70 to 1.95 MV (13.5%) was noted, which was not statistically significant (P ú 0.05, n Å 9) and mean rheobase was unaffected (5.73-5.72 nA, 00.2%, P ú 0.9, n Å 9). Similar repeated measurements over approximately the same time period without drug ad-FIG . 8. Plot of regression lines of modulation versus ln EPSP 18 Hz ampliministration revealed no significant change in mean input tude for individual motoneurons after baclofen (dark arrows) or CGP-35348 resistance (1.86-1.94 MV, 4.3%, P ú 0.6, n Å 16) or in (shaded arrows) administration. Each arrow is regression through several measurements of EPSP 18 Hz amplitude and modulation acquired at different times after drug administration (as in Fig. 6 ) and arrow indicates direction of change. Only cells for which regression line was significant (P õ 0.05) are displayed here. EPSPs from cells treated with baclofen or CGP-35348 exhibited similar slopes when plotted on semilog coordinates. Thin line is regression through similar data obtained from 103 motoneurons in untreated rats. Note that regression lines from baclofen-and CGP-35348-treated motoneurons have similar slopes which are markedly different from slope of regression line through population of motoneurons in untreated rats. mean rheobase (7.07-6.76 nA, 04.4%, P ú 0.4, n Å 33). Activation of GABA B receptors has been reported to hyperpolarize hippocampal cells via an increased K conductance (Dutar and Nicoll 1988; Gahwiler and Brown 1985) . However, no consistent change in motoneuron membrane potential was observed after baclofen or CGP-35348, either directly by measurements of membrane potential or indirectly by comparison of action-potential amplitude before and after application of these drugs. Together, these results are consistent with those from previous studies and indicate that the actions of baclofen in the Ia-motoneuron system are exclusively presynaptic, and suggest the same for CGP-35348, although more direct tests are required.
D I S C U S S I O N
In this study, Ia-motoneuron EPSP amplitude was altered by pharmacologically decreasing or increasing the probability of transmitter release and the resultant changes in EPSP amplitude modulation and potentiation were observed. A major question was whether or not the correlated changes in these synaptic variables measured in a single motoneuron would match those measured across the different motoneurons in the pool. Such an observation would strengthen the inference that probability of release of transmitter differs synapse results from an exclusively presynaptic action (Ed-shift in amplitude modulation. Substantial increases in EPSP wards et al. 1989; Lev-Tov et al. 1988 ; Peng and Frank amplitude occurred as expected; however, these were accom-1989). This is a GABA B receptor-mediated, G-protein panied by only relatively small changes in EPSP amplitude linked, direct effect on voltage-sensitive Ca 2/ channels (i.e., modulation toward more negative values. Assuming that the not through second messengers) leading to a decrease in magnitude and sign of modulation depends on the balance Ca 2/ entry into the presynaptic terminals (Dunlap and Fischbetween residual Ca 2/ and transmitter depletion, it appears bach 1981) and a decrease in the probability of transmitter that this balance measured as a function of the change in release (Deisz and Lux 1985; Dolphin and Scott 1987) . EPSP amplitude is affected differently by baclofen and by GABA B receptors have been reported at the sites of pre-CGP-35348. These differences in the responses to the sumed Ia-afferent terminals in receptor-binding experiments GABA B receptor agonist and antagonist may relate to the (Bowery et al. 1987; Price et al. 1984 ). In the present study, EPSPs being in different portions of the amplitude spectrum, no significant change in motoneuron rheobase, input resiswhich was the result of treatments that altered Ca 2/ influx tance, or membrane potential was observed after either in opposite directions. These findings are consistent with baclofen or CGP-35348 administration (see also Lev-Tov et a nonlinear relationship between probability of transmitter al. 1988), consistent with the lack of a postsynaptic effect, release, EPSP amplitude and modulation, probably closer to although the change in decay time of some of the EPSPs a semilogarithmic relationship (Fig. 8) , as has been found provides some challenge to the generality of that conclusion. in the cat (Collins et al. 1988 ). The cellular basis for this Quantal analysis has revealed a reduction in quantal content nonlinearity is presently unknown, but it is important to rather than in quantal amplitude after baclofen administrarecognize that transmitter release is probably not uniform at tion (Edwards et al. 1989; Peng and Frank 1989 ), suggesting the different release sites of a given afferent (Redman 1990 ; no desensitization of postsynaptic receptors mediating the Walmsley et al. 1988 ) and this could be a source of nonlin-Ia EPSP, although this may not be generally true (see Disearity in these relationships. cussion section in Otis and Trussell 1996) . Furthermore, Manipulation of GABA B receptor activity led to a much baclofen has similar effects on proximally and distally genersteeper change in EPSP amplitude modulation as a function ated EPSPs suggesting no selective effect on synaptic inputs of EPSP amplitude than was observed when these variables to distal dendrites (Edwards et al. 1989) . The lack of an were compared across the motoneuron pool. Because the effect of baclofen on terminal potentials (Lev-Tov et al. GABA B receptor controls Ca 2/ channel activity, manipula-1988; Peng and Frank 1989) and on the electrical component tion of its activity can be assumed to affect probability of of mixed electrical/chemical synapses (Peng and Frank release as confirmed by studies of quantal release variables. 1989; Shapovalov and Shiriaev 1982) argues against an ef-Thus the finding that manipulation of probability of release fect on impulse invasion into the terminals. Antagonism of directly results in a much steeper slope for the relationship GABA B receptors via CGP-35348 is also likely presynaptic, between EPSP amplitude modulation and EPSP amplitude although direct effects on postsynaptic receptor sensitivity than what is observed across the motoneuron pool suggests cannot yet be ruled out for this drug.
that differences in EPSP amplitude in different motoneurons Baclofen administration resulted in a marked decrease in are not the result of systematic differences in probability of EPSP amplitude that was coincident with a shift from negatransmitter release. Rather it seems likely in the rat that most tive to positive (or an increase in positive) amplitude moduof the differences in EPSP amplitude across the motoneuron lation, whereas CGP-35348 produced the opposite increase pool are the result of other factors such as the convergence in EPSP amplitude and a negative shift in modulation. A of afferents, number of boutons per afferent, and motoneuron likely explanation for the positive shift in amplitude modulainput resistance. tion with baclofen is diminished Ca 2/ entry into the termi-In the cat a much stronger correlation has been described nals resulting in a decreased probability of transmitter release across the motoneuron pool between modulation and EPSP and consequently less transmitter depletion and thus less amplitude than was observed here. One possible reason for EPSP depression during repetitive stimulation (see INTRO- the differences between cat and rat may relate to differences DUCTION ). The reduced depression revealed the underlying in the composition of the motoneuron pool whose members tendency of synapses to exhibit facilitation resulting in more have been suggested to retrogradely determine the transmitpositive (or less negative) amplitude modulation during ter release properties of the presynaptic terminals synapsing high-frequency Ia-afferent stimulation. A similar decrease on them (Davis and Murphey 1994; Koerber and Mendell in EPSP amplitude and positive shift in amplitude modula-1991; ). In the cat, type S motoneurons tion has been observed in the in vitro neonatal rat spinal make up about 25% of the medial gastrocnemius motoneuron cord when extracellular Ca 2/ concentration was reduced pool (Burke 1967), whereas in the male rat used here the (Pinco and Lev-Tov 1993; Seebach and Mendell 1996) .
percentage of type S motoneurons has been estimated at The opposite effects on EPSP amplitude and amplitude about 10% (Gardiner 1993) . Because type S motoneurons modulation during high-frequency stimulation would be exin the cat display the most consistent negative values of pected to occur after CGP-35348 administration because of modulation (Mendell et al. 1995) , we can infer that in the an increase in Ca 2/ current in Ia terminals (release from present experiments in the rat these were few in number. GABA B -induced decrease in Ca 2/ entry). The increased Furthermore, no values of modulation ú55% were seen in Ca 2/ entry would elevate probability of transmitter release the rat in contrast to values ú75% seen regularly in the cat and residual Ca 2/ , but this enhanced release would also at connections on type F motoneurons with small EPSPs increase transmitter depletion, tending to mask any underlying facilitation. Thus the net effect expected is a negative (Collins et al. 1988; Mendell et al. 1995 factors likely contribute to the shallow slope in the modula- (Davis et al. 1985 (Davis et al. , 1987 . Thus the composite EPSP is likely to have properties similar to those of the single fiber EPSPs tion versus amplitude relationship in the rat.
The uniform decrease in potentiation after baclofen is con-of which it is composed. The possibility that transmitter release from different sites of the same afferent differs sistent with the mechanism of action of this agent, i.e., decreasing Ca 2/ entry into the presynaptic terminals. This does (Redman 1990; Walmsley et al. 1988 ) also emphasizes the need to consider the present results as averages. However, not agree with previous reports of an increase in potentiation after baclofen (Lev-Tov et al. 1988 ). However, the changes it is clear that these averages were affected in a consistent manner by the various treatments carried out here. in potentiation after baclofen in that experiment likely resulted from the removal of the profound depression that
In conclusion, a major objective of these experiments was to determine whether manipulation of probability of trans-follows the 30-s, 500-Hz train used as the conditioning burst. The brief bursts used in the present experiments do not have mitter release at connections on a given motoneuron would cause correlated changes in EPSP amplitude and frequency-this complication (see Davis et al. 1985 Davis et al. , 1987 . It is interesting that baclofen produces a decrease in potentiation after dependent amplitude modulation similar to those seen across the population of motoneurons. Qualitatively, the similarity the burst but a tendency to exhibit more facilitation during the burst. This implies that different mechanisms account for of these relationships is indicative of a common process.
However, the correlated changes in modulation and ampli-the enlarged EPSPs during and after the burst. As discussed above, the behavior during the burst may be determined by tude were much greater after pharmacological manipulation of EPSP amplitude via CGP-35348 and particularly after the balance between transmitter depletion and facilitation resulting from residual Ca 2/ , whereas for at least 2 s after baclofen than at synapses of different amplitude across the motoneuron pool. Assuming that the pharmacological ma-the burst the residual Ca 2/ may be dominant. Unexpectedly, a decrease in potentiation was observed after CGP-35348 nipulations affected mainly probability of transmitter release, this suggests that differences in this factor play only when enhanced Ca 2/ entry might have been expected to increase it. We speculate that other mechanisms, e.g., inter-a minor role in determining EPSP amplitude across the motoneuron pool in the rat. It remains to be seen whether these ference with transmitter replenishment or a very efficient Ca 2/ pump, may be operating under these conditions and pharmacological manipulations would suggest a more prominent role for probability of transmitter release in the deter-that this may also account in part for the relatively small changes in modulation induced by CGP-35348. mination of EPSP amplitude as has been suggested to occur in the cat ). The fact that CGP-35348 results in an increase in Iamotoneuron EPSP amplitude in the absence of baclofen indicates the presence of tonic GABA B -mediated presynaptic We thank T. C. Cope for valuable comments on a draft of this manuscript. inhibition in this system, although not excluding a possible ever it is important to note that our observations, like those of Peng and Frank (1989) , reflect the level of tonic presynaptic inhibition of unknown origin, whereas Stuart and Redman REFERENCES (1992) induced presynaptic inhibition by a conditioning vol-BETZ, W. J. Depression of transmitter release at the neuromuscular junction ley to the posterior biceps-semitendinosus nerve. More reof the frog. J. Physiol. (Lond.) 206: 629-644, 1970. cently, the GABA B receptor has been reported to be involved BOWERY, N. G., HUDSON, A. L., AND PRICE, G. W. GABA A and GABA B in the tonic component of the segmentally evoked presynapreceptor site distribution in the rat central nervous system. Neuroscience 20: 365-383, 1987. tic inhibition of the lumbar extensor monosynaptic reflexes BURKE, R. E. Motor unit types of cat triceps surae muscle. J. Physiol.
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